Fuller Rw

595 citations
50 papers · 539 · h-index 12

Impact in

Papers in

In The Last Decade

Fuller Rw

49 papers receiving 488 citations

Peers

Fuller Rw
Comparison fields: 5 of 80
  • Behavioral Neuroscience 118
  • Biological Psychiatry 48
  • Cellular and Molecular Neuroscience 256
  • Endocrine and Autonomic Systems 43
  • Pharmacology 89
Replace Miroslawa Hauptmann with:
Miroslawa Hauptmann Poland
Joanna Siwanowicz Poland
Elizabeth Erdelyi United States
Subir K. Chanda United States
I.H. Ayhan Türkiye
Russell A. Gazzara United States
Fernando Barturen Spain
Paul R. Draskóczy United States
Sylvie Girardon France
Miljana Simonovic United States
Fuller Rw relative to Miroslawa Hauptmann Poland Miroslawa Hauptmann's profile →
Citations per field
00.5×1.6×
Miroslawa Hauptmann · 1×
Citations per year

Countries citing papers authored by Fuller Rw

Since Specialization
Citations

This map shows the geographic impact of Fuller Rw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuller Rw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuller Rw more than expected).

Fields of papers citing papers by Fuller Rw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuller Rw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuller Rw. The network helps show where Fuller Rw may publish in the future.

Co-authors

The 1 scholars most cited alongside Fuller Rw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fuller Rw Line = papers co-authored together Fuller Rw links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The involvement of serotonin in regulation of pituitary-adrenocortical function.
1992163
2
Potentiation of the L-5-hydroxytryptophan-induced elevation of plasma corticosterone levels in rats by a specific inhibitor of serotonin uptake.
197530
3
Selective inhibition of monoamine oxidase.
197230
4
The human pharmacology of capsaicin.
199021
5
Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats.
198721
6
Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
198519
7
Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase.
198117
8
Pharmacologic modification of serotonergic function: drugs for the study and treatment of psychiatric and other disorders.
198616
9
Inhibition of drug metabolism by fluoxetine.
197616
10
Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
196815
11
Biochemical pharmacology of the serotonin system.
198613
12 197513
13
Persistent effects of amphetamine, p-chloroamphetamine, and related compounds on central dopamine and serotonin neurons in rodents.
198512
14
Further evidence for serotonin involvement in thermoregulation following morphine administration from studies with an inhibitor of serotonin uptake.
197412
15
Effect of fluoxetine pretreatment on plasma and tissue concentrations of desipramine in rats.
198911
16
Central serotonin antagonist activity of ketanserin.
19849
17
Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP.
19869
18
1-(1-Naphthyl)piperazine, a central serotonin agonist.
19868
19
Functional consequences of inhibiting serotonin uptake with fluoxetine in rats.
19828
20
Pharmacologic properties of serotonergic agents and antidepressant drugs.
19878

About Fuller Rw

Fuller Rw is a scholar working on Cellular and Molecular Neuroscience, Biochemistry, Pharmaceutical Science, Pharmacology and Organic Chemistry, having authored 50 papers that have together received 539 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (15 papers), Neuroscience and Neuropharmacology Research (8 papers), Amino Acid Enzymes and Metabolism (6 papers), Diet and metabolism studies (5 papers), Receptor Mechanisms and Signaling (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Chemical Reactions and Isotopes (3 papers) and Cyclopropane Reaction Mechanisms (3 papers). The work is most often cited by research in Behavioral Neuroscience (118 citations), Biological Psychiatry (48 citations), Cellular and Molecular Neuroscience (256 citations), Endocrine and Autonomic Systems (43 citations) and Pharmacology (89 citations). Fuller Rw has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Saunders Kb. Their work appears in journals such as Toxicology and Applied Pharmacology and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact